These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 26264222)
21. FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer. Weng W; Okugawa Y; Toden S; Toiyama Y; Kusunoki M; Goel A Clin Cancer Res; 2016 Oct; 22(19):4947-4957. PubMed ID: 27162244 [TBL] [Abstract][Full Text] [Related]
22. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells. Duan N; Hu X; Yang X; Cheng H; Zhang W Int J Clin Exp Pathol; 2015; 8(9):10250-60. PubMed ID: 26617733 [TBL] [Abstract][Full Text] [Related]
24. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells. Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723 [TBL] [Abstract][Full Text] [Related]
25. PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Li H; Yin C; Zhang B; Sun Y; Shi L; Liu N; Liang S; Lu S; Liu Y; Zhang J; Li F; Li W; Liu F; Sun L; Qi Y Carcinogenesis; 2013 Sep; 34(9):2145-55. PubMed ID: 23671127 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer. Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421 [TBL] [Abstract][Full Text] [Related]
27. FOXC2 promotes colorectal cancer metastasis by directly targeting MET. Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744 [TBL] [Abstract][Full Text] [Related]
29. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis. Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864 [TBL] [Abstract][Full Text] [Related]
30. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer. Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076 [TBL] [Abstract][Full Text] [Related]
31. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer. Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278 [TBL] [Abstract][Full Text] [Related]
32. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424 [TBL] [Abstract][Full Text] [Related]
33. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop. Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179 [TBL] [Abstract][Full Text] [Related]
34. LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression. Wu Y; Liu M; Li Z; Wu XB; Wang Y; Wang Y; Nie M; Huang F; Ju J; Ma C; Tan R; Zen K; Zhang CY; Fu K; Chen YG; Wang MR; Zhao Q Oncotarget; 2015 Oct; 6(32):32890-901. PubMed ID: 26413750 [TBL] [Abstract][Full Text] [Related]
35. Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression. Xue J; Zhou A; Tan C; Wu Y; Lee HT; Li W; Xie K; Huang S J Biol Chem; 2015 Jul; 290(30):18662-70. PubMed ID: 26085085 [TBL] [Abstract][Full Text] [Related]
36. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion. Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1. Xia LM; Huang WJ; Wang B; Liu M; Zhang Q; Yan W; Zhu Q; Luo M; Zhou ZZ; Tian DA J Cell Biochem; 2009 Feb; 106(2):247-56. PubMed ID: 19097132 [TBL] [Abstract][Full Text] [Related]
38. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Uddin S; Ahmed M; Hussain A; Abubaker J; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Jehan Z; Bavi P; Siraj AK; Al-Kuraya KS Am J Pathol; 2011 Feb; 178(2):537-47. PubMed ID: 21281787 [TBL] [Abstract][Full Text] [Related]
39. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression. Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972 [TBL] [Abstract][Full Text] [Related]
40. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]